Industry Insights
Exploring the Challenges and Opportunities of Harvesting CTCs
Industry InsightIn a recent study, CTCs were harvested to investigate the causes of brain metastasis in non-small cell lung cancer patients. We spoke to Andrew Newland, CEO, ANGLE, to learn more about the study, the challenges of harvesting CTCs and how the Parsortix system overcomes some of these challenges.
Read More
Capturing the Transcriptome and the Epigenome Simultaneously in Single Cells
Industry InsightHow do we take our understanding of the different stages of the omics cascade to the next level? We analyze them simultaneously. With the recent launch of its Chromium Single Cell Multiome ATAC + Gene Expression solution, 10x Genomics is making advances towards that goal. Technology Networks spoke with Ben Hindson to learn more.
Read More
Exploring Genetic Variation and COVID-19 Clinical Variability
Industry InsightOne of the biggest challenges that scientists and healthcare professionals are facing during the COVID-19 pandemic is the high rate of clinical variability. Whilst some patients present as asymptomatic, others are developing more severe symptoms such as pneumonia, and some cases are ultimately proving fatal. Why? We speak with Dr Salvatore Viscomi to learn more.
Read More
Pushing the Boundaries of Translational Molecular Imaging
Industry InsightProfessor Ron Heeren recently embarked on a study to bring together the spatial molecular information that is provided by MALDI-MSI with the microproteomic characterization generated by LC-MS on the same tissue specimen, on a single instrument. Heeren and colleagues were successful in this feat. Their work is published in the journal Proteomics and forms the basis of this interview.
Read More
A New SARS-CoV-2 Descriptive Diagnostic Test – What Makes This Assay Different to Others?
Industry InsightClear Labs is a company focused on the latest technologies in molecular testing, machine learning, automation and bioinformatics – it develops fully automated next-generation sequencing and in vitro diagnostics solutions. Technology Networks had the pleasure of speaking with ClearLabs’ CEO Sasan Amini, to learn more about the company’s NGS-based COVID test, Clear Dx™.
Read More
LAMP-Based Testing for COVID-19
Industry InsightTechnology Networks recently spoke to Dr Gary Keating, Chief Technical Officer at Hibergene Diagnostics, to learn more about LAMP technology and the advantages it could offer for COVID-19 testing. Gary also discussed some of the challenges faced when developing diagnostics and how the COVID-19 pandemic has impacted diagnostic design and manufacturing.
Read More
COVID-19 Antibody Testing: S vs. N Protein
Industry InsightTechnology Networks spoke to Dr Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN US, to learn about the differences between the S and N proteins and what makes them suitable as target antigens in serology testing. Iswariya also discussed the findings and implications from a study which cautioned against the extensive use of tests that detect antibodies against the N protein only.
Read More
Exploring SARS-CoV-2 Antibody Testing
Industry InsightTechnology Networks spoke to Jeff Hawkins, Dr Jerry Yeo, and Dr Abhijit Datta, to learn how the information provided by antibody tests can be used appropriately during the COVID-19 pandemic.
Read More
Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry InsightT cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.
Read More
Ultra-High-Throughput Proteomics To Discover New Biomarkers To Predict COVID-19 Severity
Industry InsightIn a study recently published in Cell Systems, a new ultra-high-throughput proteomics method was used to identify 27 blood biomarkers that distinguished COVID-19 patients with mild or severe responses. We spoke to Dr Markus Ralser to learn more about the study and how the method could potentially be used in the clinic to diagnose COVID-19 severity.
Read More
